menu search

Gsk reportedly set to shake up r&d opertion

GSK PLC (LSE:GSK, NYSE:GSK) is set to restructure its research division, impacting scientists in the UK, the US, and Belgium, according to the Sunday ...

October 9, 2023, 2:14 am

Novavax's updated covid vaccine can still catch up to pfizer, moderna shots this fall

Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans — but analysts aren't worried about tha...

October 7, 2023, 8:00 am

This could be novavax's big opportunity

Novavax is about to join Moderna and Pfizer in the fall vaccine marketplace. The company just won a nod...

October 7, 2023, 5:30 am

Defence to present three of its leading products at the upcoming festival of biologics in basel, switzerland

Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the ...

October 6, 2023, 6:00 pm

Nobel for mrna: which other biotech stocks might be overlooked?

Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until ...

October 6, 2023, 8:33 am

Why is vaccinex (vcnx) stock up 26% today?

Vaccinex (NASDAQ: VCNX ) stock is climbing higher on Friday after the clinical-stage biotechnology com...

October 6, 2023, 8:08 am

Did moderna just jump ahead of rivals in a potential billion-dollar market?

Moderna just reported positive data from its combined flu/coronavirus vaccine candidate and aims to lau...

October 6, 2023, 6:00 am

Investing in moderna: a speculative buy for long-term gains

Moderna is a biotech company with high potential upside, despite the decline in demand for its COVID-19 vaccin...

October 5, 2023, 3:21 pm

Moderna (mrna) to advance covid/flu combo jab to late-stage study

Moderna's (MRNA) intends to start the late-stage study on its COVID-19-influenza combination vaccine ca...

October 5, 2023, 12:02 pm

Moderna reportedly files submission for rsv vaccine with health canada

Moderna Therapeutics Inc (NASDAQ:MRNA) has filed a new drug submission for its vaccine aimed at prevent...

October 5, 2023, 11:41 am

Can moderna achieve its most ambitious goal yet?

Investors have worried about Moderna's post-pandemic earnings since the company relies on its coronavirus vacc...

October 5, 2023, 5:30 am

Valneva's vaccination valor: a buy rating justified

Valneva's 1H 2023 revenue declined compared to the previous year, but product sales more than doubled, driven by the recovery in the travel market. Th...

October 4, 2023, 11:45 pm

Gritstone bio announces presentations from phase 1 studies evaluating next-generation vaccine candidate for covid-19 at idweek 2023

EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop t...

October 4, 2023, 8:05 pm

Catalent remains overvalued

Catalent, Inc.'s revenue and scale have suffered due to the decline in vaccine deliveries, particularly...

October 4, 2023, 1:08 pm

Moderna ceo on combo covid, flu vaccine moving to next trial phase

A lot of Americans are planning on getting both a flu shot and Covid booster this fall. But Moderna (MRNA) has been working on a combination flu and C...

October 4, 2023, 12:55 pm

Novavax (nvax) up 8% on fda nod for updated covid booster jab

Novavax's (NVAX) updated COVID vaccine is authorized under emergency use for individuals aged 12 years ...

October 4, 2023, 12:46 pm

Moderna reports positive results for combination flu and covid vaccine

Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine again...

October 4, 2023, 8:09 am

Moderna combo covid-19/flu vaccine succeeds in early-stage trial

Moderna on Wednesday said its combination vaccine to protect against both COVID-19 and influenza genera...

October 4, 2023, 7:07 am

Io biotech announces three poster presentations at the society for immunotherapy of cancer’s (sitc) 38th annual meeting

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 3, 2023, 8:30 pm

Takeda's dengue vaccine gets who group's recommendation

American depositary receipts of Takeda Pharmaceutical Co. 4502, -1.79% TAK, -2.16% rose more than 1% in the extended session Tuesday after the Japan-b...

October 3, 2023, 5:36 pm


Search within

Pages Search Results: